Medikografi   Nootropics

Acetyl L-Carnitine (ALCAR)

​

​

L-Carnitine and Acetyl-L-carnitine Roles and Neuroprotection in Developing Brain.

 

Acetyl-L-carnitine for the treatment of diabetic peripheral neuropathy.

 

Significance of l-carnitine for human health.

 

Acetyl-L-carnitine for patients with hepatic encephalopathy.

 

Acetyl-L-carnitine. Monograph.

 

Role of L-carnitine in female infertility.

 

Natural products - alpha-lipoic acid and acetyl-L-carnitine - in the treatment of chemotherapy-induced peripheral neuropathy.

 

L-carnitine for cognitive enhancement in people without cognitive impairment.

 

Acetyl-L-carnitine for dementia.

 

Clinical practice guidelines on the evidence-based use of integrative therapies during and after breast cancer treatment.

 

Oral acetyl-L-carnitine treatment in hepatic encephalopathy: view of evidence-based medicine.

 

Mechanisms of ischemic neuroprotection by acetyl-L-carnitine.

 

Acetyl-L-carnitine in the treatment of peripheral neuropathic pain: a systematic review and meta-analysis of randomized controlled trials.

Treating Painful Diabetic Peripheral Neuropathy: An Update.

 

Natural products and complementary therapies for chemotherapy-induced peripheral neuropathy: A systematic review.

 

Effect of L-carnitine and/or L-acetyl-carnitine in nutrition treatment for male infertility: a systematic review.

 

Peripheral neuropathy: pathogenic mechanisms and alternative therapies.

 

Cognitive remission: a novel objective for the treatment of major depression?

 

Clinical practice guidelines on the use of integrative therapies as supportive care in patients treated for breast cancer.

 

Drug treatment for spinal muscular atrophy types II and III.

 

Critical update for the clinical use of L-carnitine analogs in cardiometabolic disorders.

Carnitine for fatigue in multiple sclerosis.

 

Nutrients and HIV: part three - N-acetylcysteine, alpha-lipoic acid, L-glutamine, and L-carnitine.

 

l-Acetylcarnitine: A Mechanistically Distinctive and Potentially Rapid-Acting Antidepressant Drug.

 

Medical management of Peyronie's disease.

 

Chemotherapy-induced neurotoxicity: the value of neuroprotective strategies.

 

Management of the aging risk factor for Parkinson's disease.

 

Cellular stress responses, hormetic phytochemicals and vitagenes in aging and longevity.

 

Natural substances and Alzheimer's disease: from preclinical studies to evidence based medicine.

 

Diabetic neuropathy and oxidative stress: therapeutic perspectives.

 

New insights concerning the role of carnitine in the regulation of fuel metabolism in skeletal muscle.

 

Natural antioxidants and hypertension: promise and challenges.

 

Pyruvate dehydrogenase complex: metabolic link to ischemic brain injury and target of oxidative stress.

 

Functional Expression of Organic Ion Transporters in Astrocytes and Their Potential as a Drug Target in the Treatment of Central Nervous System Diseases.

 

The collective therapeutic potential of cerebral ketone metabolism in traumatic brain injury.

 

Debate forum: levocarnitine therapy is rational and justified in selected dialysis patients.

 

Supplemental substances derived from foods as adjunctive therapeutic agents for treatment of neurodegenerative diseases and disorders.

 

Comparative Safety of Pharmacologic Treatments for Persistent Depressive Disorder: A Systematic Review and Network Meta-Analysis.

 

Mitochondria in the elderly: Is acetylcarnitine a rejuvenator?

 

Oxidative damage and mitochondrial decay in aging.

​

​